Trending

Jazz Pharmaceuticals

Priority review voucher prices fall again after Spark’s $110m sale

Priority review voucher prices fall again after Spark’s $110m sale

Voucher prices have fallen since their 2015 peak

X

Priority review voucher prices fall again after Spark’s $110m sale

https://pharmaphorum.com/news/spark-sells-priority-review-voucher-to-jazz/

EUSA Pharma looks to further in-licensing to build growth

EUSA Pharma looks to further in-licensing to build growth

Specialist company EUSA Pharma is looking for new medicines to develop after getting two cancer drugs recommended by European

X

EUSA Pharma looks to further in-licensing to build growth

https://pharmaphorum.com/news/uks-eusa-pharma-looks-bolster-pipeline/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com